Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0

Gabaklas-NT Tablet

Prescription Icon
Prescription Required

Marketer

Alniche Life Sciences Pvt Ltd

Salt Composition

Gabapentin (400mg) + Nortriptyline (10mg)

Overview Gabaklas-NT Tablet

Neuropathic pain is effectively managed with Gabaklas-NT tablets, a combination medication. Its mechanism involves interrupting pain signal transmission to the brain, thus reducing pain perception. Gabaklas-NT should be taken orally, once daily, preferably at bedtime, with or without food. Consistent daily dosing ensures therapeutic blood levels. Missed doses should be taken immediately upon recall. Complete the prescribed course, regardless of symptom improvement. Abrupt cessation should be avoided; consult your doctor before discontinuing. Common side effects include constipation, urinary difficulty, weight gain, fatigue, and dry mouth. Dizziness and drowsiness may occur; avoid driving or activities requiring alertness until the effects are known. Weight gain is possible; counter this through regular exercise and a healthy diet. Report any unusual mood changes, including suicidal thoughts, to your physician immediately, as these can be associated with this medication. Prior to commencing treatment, disclose any kidney or liver conditions, and all other medications you are using, as interactions may impact efficacy or alter the drug's action. Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.

Uses of Gabaklas-NT Tablet

Managing neuropathic pain

Major Benefits of Gabaklas-NT Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for Gabaklas-NT Tablets. Ingest the tablets whole; avoid chewing, crushing, or breaking them. Gabaklas-NT Tablets can be administered with or without food, although consistent timing is recommended.

Common Side effects of Gabaklas-NT Tablet:

  • Dryness in mouth
  • Decreased white blood cell count
  • Peripheral edema
  • Weakness
  • Impotence
  • Indigestion
  • Insomnia (difficulty in sleeping)
  • Tiredness
  • Orthostatic hypotension (sudden lowering of blood pressure on standing)
  • Increased heart rate
  • Uncoordinated body movements
  • Constipation
  • Difficulty in urination
  • Weight gain
  • Sleepiness
  • Dizziness
  • Blurred vision

How to use Gabaklas-NT Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Gabaklas-NT Tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, but consistent timing is recommended.

How Gabaklas-NT Tablet works:

Gabaklas-NT tablets contain gabapentin and nortriptyline, working synergistically to alleviate neuropathic pain. Gabapentin, an alpha-2-delta ligand, reduces pain transmission by modulating nerve cell calcium channels. Nortriptyline, a tricyclic antidepressant, elevates serotonin and noradrenaline levels, thus inhibiting pain signal propagation within the central nervous system. This dual mechanism effectively targets nerve damage-related pain.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Gabaklas-NT tablets and alcohol can lead to significant sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Gabaklas-NT Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescribing. Physician consultation is recommended.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Gabaklas-NT Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by Gabaklas-NT Tablet side effects, due to potential drowsiness induced by the medication.

KidneyKidneyCAUTION

Patients with impaired kidney function should exercise caution when using Gabaklas-NT Tablets. Dosage modification may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Gabaklas-NT tablets cautiously, potentially requiring dose modification. Physician consultation is advised. Report jaundice symptoms immediately if they appear during treatment. Gabaklas-NT tablets are contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Gabaklas-NT Tablet :

Should you forget a Gabaklas-NT Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Gabaklas-NT Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Nervous system medications

FAQs on Gabaklas-NT Tablet

Gabapentin and Nortriptyline, combined in Gabaklas-NT Tablets, provide relief from neuropathic pain. The medication works by modulating brain activity to soothe damaged or overly stimulated nerves, thus reducing pain perception.
Discontinuing Gabaklas-NT Tablet prematurely, even with pain relief, is inadvisable. Adhere to your physician's prescribed regimen. Abrupt cessation may trigger withdrawal effects including anxiety, insomnia, nausea, pain recurrence, and diaphoresis. A gradual dosage reduction is recommended prior to complete discontinuation.
Gabaklas-NT Tablets may stimulate appetite, potentially leading to increased food consumption and weight gain. Weight management is simpler than weight loss. Maintain a balanced diet without enlarging portion sizes. Limit high-calorie foods like sugary drinks, fried foods, processed snacks, and desserts. Between meals, choose fruits, vegetables, and low-calorie options instead of unhealthy snacks. Regular physical activity aids in preventing weight gain. Consistent healthy eating and exercise may prevent any weight increase associated with the medication.
Gabaklas-NT Tablet may impact sexual function in both genders. Reduced libido, erectile dysfunction (difficulty achieving or sustaining an erection), and anorgasmia are frequently reported. Decreased sexual satisfaction and discomfort during intercourse may also occur. Patients experiencing such side effects should consult their physician; however, discontinuation of Gabaklas-NT Tablet should not be undertaken without medical advice.
Gabaklas-NT Tablet rarely causes severe adverse reactions. Seek immediate medical advice if you experience: altered body temperature, respiratory distress, rapid heartbeat, fatigue, gait instability, impaired coordination or slowed reflexes, unusual mood or behavioral shifts (including agitation, anxiety, or elation), depressive symptoms, hallucinations, illogical thought processes, visual disturbances (blurred or double vision), involuntary eye movements, visual impairment, or indications of recurrent infections like fever, intense chills, pharyngitis, or oral ulcers. While infrequent, these side effects warrant prompt medical intervention.
Patients may experience initial improvements with Gabaklas-NT Tablets within two weeks, though complete therapeutic effects might not be evident for two to three months. In certain individuals, achieving optimal results may require a longer treatment duration.
Should you miss a Gabaklas-NT Tablet dose, and your next dose is nearly due, omit the missed dose and continue with your regular schedule. If your next dose is not imminent, take the missed dose immediately upon recollection, then resume your usual dosing pattern. Avoid doubling up on doses to compensate for a missed one; this could heighten the risk of adverse reactions from an overdose. For any uncertainty regarding Gabaklas-NT Tablet usage, consult your physician.
If this occurs, promptly contact your physician or proceed to the closest emergency room. This is crucial regardless of the presence or absence of symptoms. Immediate medical intervention may be necessary. An overdose of this medication can cause drowsiness, weakness, gait instability, diplopia, dysarthria, diarrhea, disorientation, blurred vision, vertigo, fluctuating body temperature, respiratory distress, and tachycardia.
Gabaklas-NT Tablets can affect cognitive function and reflexes. Exercise caution when operating machinery or engaging in activities demanding alertness. Alcohol consumption should be avoided during Gabaklas-NT Tablet use, as it may potentiate the drug's effects, posing a risk. Grapefruit and its juice may interact negatively, potentially causing adverse reactions. Minimize sun exposure and the use of tanning beds. Gabaklas-NT Tablets increase sun sensitivity; therefore, protective clothing and sunscreen are recommended during daytime outdoor activities.
Regular check-ups with your physician may be necessary following the commencement of Gabaklas-NT Tablet therapy. Consult your doctor immediately if your symptoms fail to improve with the prescribed Gabaklas-NT Tablet dosage, or if persistent adverse effects interfere with your daily life.
Gabaklas-NT Tablets can induce drowsiness or sudden sleep onset during routine tasks. This may occur without prior warning signs of drowsiness or other symptoms. Refrain from driving, operating equipment, working at heights, or engaging in hazardous activities, particularly when initiating treatment, until the medication's effects are understood. Report any such incidents to your physician while using this medication.
Increasing the prescribed dosage of medication won't necessarily enhance its effectiveness; instead, it could significantly raise the risk of adverse reactions and harmful side effects. Should your symptoms worsen despite adhering to the recommended dosage, a consultation with your physician for reassessment is advised.
Retain the medication within its original packaging until needed. Store in a cool, dry environment. Keep out of the view and reach of children. Proper disposal methods for unused medication are necessary to prevent accidental ingestion by children, pets, or others.
Gabaklas-NT Tablet
176
MRP 215
18% off